Prisys Biotechnologies

Prisys is a CRO company, pioneering in non-human primate (NHP) pharmacology, to provide peri-clinical studies of new drug development. Prisys integrated its proprietary modeling expertise and rich pharmacology experience with top-equipped local clinical hospitals, enabling global pharms to access the latest innovational approaches for more translatable and more efficient advancement of new therapeutics. With the huge unmet needs for more clinical relevance and predictions of human-target specific novel therapeutic strategies, Prisys has been continually developing different NHP models covering the following key disease areas: Inflammatory Autoimmune Cardiovascular Cerebrovascular Hematology Kidney Liver Lung Ophthalmology OB-GYN Oncology Contact us at : info@prisysbiotech.com...

Modeling disease,translational studies,nhp pharmacology,safety,non-,pre-,peri-clinical development,"adaptive or replacement clinical trials"​,spontaneous models,co-development of novel nhp models and validation of clinical endpoints,and nhp welfare

Prisys biotechnologies operates in the Biotechnology research industry.

Prisys biotechnologies's revenue is 11m - 100m

Prisys biotechnologies has 11 - 50 employees.